Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty: A Prospective Multi-Centre Cohort Study

NCT04277416 is registered in ClinicalTrials.gov with Ortho Development Corporation as lead sponsor.

NCT NCT04277416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04277416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty: A Prospective Multi-Centre Cohort Study
Lead sponsor
Ortho Development Corporation
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 28, 2020
Completion date
December 31, 2032
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total hip arthroplasty, total hip replacement